Gilead Sciences
GILD
#126
Rank
C$212.28 B
Marketcap
C$171.08
Share price
-1.90%
Change (1 day)
35.74%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): C$13.85 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are C$29.08 Billion. In 2024 the company made an earning of C$0.96 Billion a decrease over its 2023 earnings that were of C$9.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$13.85 B1339.37%
2024 C$0.96 B-89.94%
2023 C$9.56 B17.97%
2022 C$8.11 B-29.77%
2021 C$11.54 B395.99%
2020 C$2.32 B-67.66%
2019 C$7.19 B-33.84%
2018 C$10.88 B-42.35%
2017 C$18.87 B-20.87%
2016 C$23.85 B-21.06%
2015 C$30.21 B45.8%
2014 C$20.72 B253.01%
2013 C$5.87 B16.51%
2012 C$5.03 B-1.07%
2011 C$5.09 B-6.71%
2010 C$5.46 B11.75%
2009 C$4.88 B29.5%
2008 C$3.77 B19.11%
2007 C$3.16 B-455.74%
2006 -C$0.9 Billion-154.93%
2005 C$1.62 B76.99%
2004 C$0.91 B-266.16%
2003 -C$0.56 Billion-638.24%
2002 C$0.10 B31.5%
2001 C$77.87 M-242.15%
2000 -C$54.79 Million-40.2%
1999 -C$91.62 Million31.85%
1998 -C$69.49 Million8.73%
1997 -C$63.91 Million27.22%
1996 -C$50.23 Million
1994 -C$47.86 Million26.57%
1993 -C$37.82 Million46.49%
1992 -C$25.82 Million362.5%
1991 -C$5.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.50 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.22 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.31 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.38 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.65 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.53 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$45.19 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.39 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$32.21 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA